Filing Details
- Accession Number:
- 0000014272-17-000206
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-13 17:31:02
- Reporting Period:
- 2017-12-12
- Accepted Time:
- 2017-12-13 17:31:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1474056 | Jr. J. Thomas Lynch | Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154 | Evp & Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Disposition | 2017-12-12 | 5,300 | $63.24 | 9,251 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These shares were sold to cover taxes in connection with the settlement of Deferred Share Units. Deferred Share Units convert into a share of common stock upon settlement.
Billionaire Hedge Funds
